Share This

PR Newswire Asia's news > Biotechnology

 |   Detail   |   Print    Next page > 
     
Eluminex Biosciences Announces FDA Acceptance of Investigational New Drug (IND) Application for EB-105 - A Novel Trispecific Fusion Antibody for Diabetic Macular Edema (DME) - and Upcoming Scientific Presentations
2024-04-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
National Medical Products Administration (NMPA) Approves Chipscreen Bioscience's Chidamide (Epidaza) combined with R-CHOP for the treatment of diffuse large B-cell lymphoma
2024-04-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
A Potential First-In-Class Drug: CDE Approved Single-Arm Pivotal Clinical Study of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs
2024-04-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia
2024-04-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
HanAll Biopharma Reports Q1 2024 Financial Results and Provides Business Update
2024-04-30T    Banking/Financial Service   Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Innovation showcase displays growing influence
2024-04-30T    Banking/Financial Service   Biotechnology   Computer/Electronics   Internet Technology 
BioWorld by Clarivate Explores the Future of CAR T Therapy in Mainland China in Special Report
2024-04-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals   Publishing/Information Service 
Innovent Announces the Appointment of Dr. Samuel Zhang as Global Chief Business Officer (CBO)
2024-04-30T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
WuXi Biologics Releases 2023 ESG Report Demonstrating Strong Sustainability Commitment
2024-04-30T    Biotechnology   Environmental Products & Services   Health Care/Hospital   Medical/Pharmaceuticals 
CARsgen Submitted Responses to FDA Observations
2024-04-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
  Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.